Common use of Purpose of the Specification Clause in Contracts

Purpose of the Specification. To ensure a consistent and equitable approach across England,a common national service specification must be used to govern the provision and monitoring of the NHS Newborn Blood Spot (NHS NBS) screening services. The purpose of the service specification for the NBS Screening Programme is to outline the service and quality indicators expected by NHS England and NHS Improvement for its responsible population and which meets the evidence base, policies, recommendations and standards of the UK National Screening Committee. The service specification is not designed to replicate, duplicate or supersede any relevant legislative provisions that may apply, e.g. the Health and Social Care Act 2012 or the work undertaken by the Care Quality Commission. The specification will be reviewed and amended in line with any new guidance as quickly as possible. This specification should be read in conjunction with: • Programme standards ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/collections/nhs-population- screening-programme-standards • Programme national annual data reporting ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/ collections/newborn-blood-spot-screening-programme-standards-and-data • NHS screening programmes ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/collections/nhs- screening-programmes-national-data-reporting • NHS population screening failsafe procedures ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/ collections/nhs-population-screening-failsafe-procedures • Programme supporting publications ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/collections/ newborn-blood-spot-screening-programme-supporting-publications • Safety concerns, safety incidents and serious incidents. Managing Safety Incidents in NHS National Screening Programmes ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/ publications/managing-safety-incidents-in-nhs-screening-programmes • National Institute for Health and Clinical Excellence (NICE) Clinical guideline 37 Routine and postnatal care of women and their babies 2006 ▇▇▇▇://▇▇▇.▇▇▇▇.▇▇▇.▇▇/ guidance/cg37 The national screening team in Public Health England (PHE Screening) provides expert advice and support to the NHS Screening Programme. It does those things which make sense to do once rather than by each individual screening service. This includes: • developing and monitoring standards • producing public information leaflets • quality assurance of local screening services • enabling accessible training and education Providers should subscribe to the PHE Screening blog for the latest national news and updates. National documentation and guidance is published on ▇▇▇.▇▇.‌‌‌‌

Purpose of the Specification. To ensure a consistent and equitable approach across England,England a common national service specification must be used to govern the provision and monitoring of fetal anomaly ultrasound screening services as part of the NHS Newborn Blood Spot Fetal Anomaly Screening Programme (NHS NBS) screening servicesFASP). The purpose of the service specification for the NBS Screening Programme is to outline the service and quality indicators expected by NHS England and NHS Improvement for its the population for whom it is responsible population and which meets the evidence base, policies, recommendations and standards of the UK National Screening CommitteeNHS Fetal anomaly screening programme. The service This specification is not designed designated to replicate, duplicate or supersede any relevant legislative provisions that which may apply, e.g. of the Health and Social Care Act 2012 2008 or the work undertaken by the Care Quality Commission. The specification will be reviewed and amended in line with any new guidance as quickly as possible. This specification should be read in conjunction with: • Programme standards current FASP guidance ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/topic/population-screening- programmes/fetal-anomaly • FASP Screening programme handbook ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/publications/fetal-anomaly-screening- programme-handbook . • FASP Ultrasound Practitioners Handbook ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/publications/fetal-anomaly-screening-ultrasound- practitioners-handbook • FASP Laboratory Handbook ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/publications/fetal- anomaly-screening-laboratory-handbook-▇▇▇▇▇-▇▇▇▇▇▇▇-and-pataus- syndromes • any separate service specifications for the screening laboratory used by the Provider for antenatal screening services • UK NSC Guidance, Managing Safety Incidents in the English NHS National Screening Programmes ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/publications/managing-safety-incidents-in- nhs-screening-programmes • Guidance & updates on Key Performance Indicators can be found at ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/collections/nhs-population- screening-programme-standards • Programme national annual data reporting ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/ collections/newborn-blood-spot-screening-programme-standards-and-data • NHS screening programmes ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/collections/nhs- screening-programmes-national-national- data-reporting • NHS population screening failsafe procedures ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/ collections/nhs-population-screening-failsafe-procedures • Programme supporting publications ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/collections/ newborn-blood-spot-screening-programme-supporting-publications • Safety concerns, safety incidents and serious incidents. Managing Safety Incidents in NHS National Screening Programmes ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/ publications/managing-safety-incidents-in-nhs-screening-programmes • National Institute for Health and Clinical Excellence (NICE) Clinical guideline 37 Routine and postnatal 62 Antenatal care of women and their babies 2006 June 2010 ▇▇▇▇://▇▇▇.▇▇▇▇.▇▇▇.▇▇/ guidance/guidance/cg37 The national screening team in Public CG62 • National Institute for Health England and Clinical Excellence (PHE ScreeningNICE) provides expert advice and support to the NHS Screening Programme. It does those things which make sense to do once rather than by each individual screening service. This includes: • developing and monitoring standards • producing public information leaflets • quality assurance of local screening services • enabling accessible training and education Providers should subscribe to the PHE Screening blog for the latest national news and updates. National documentation and guidance is published on Clinical guideline CG 129 Antenatal care September 2011 ▇▇▇▇://▇▇▇.▇▇.‌‌‌‌▇▇.▇▇▇.▇▇/guidance/CG129 • Royal College of Radiologists. Providing an Ultrasound Service ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇.▇▇/publication/standards-provision-ultrasound-service • Service specification No16 NHS Fetal Anomaly Screening Programme – Screening for Down’s, ▇▇▇▇▇▇▇’ and Patau’s syndromes ( trisomy 21,18 & 13) ▇▇▇▇▇://▇▇▇.▇▇▇▇▇▇▇.▇▇▇.▇▇/commissioning/wp- content/uploads/sites/12/2016/02/serv-spec-16.pdf • ‘Maternity Pathway Payments: Who pays for what?-Aspects of the Maternity Pathway Payment for the Screening and Immunisations Programmes June 2015 ▇▇▇▇▇://▇▇▇.▇▇▇▇▇▇▇.▇▇▇.▇▇/expo/wp- content/uploads/sites/18/2015/06/who-pays-mpp-upd-06-2015.pdf

Purpose of the Specification. To ensure a consistent and equitable approach across England,England a common national service specification must be used to govern the provision and monitoring of Down’s, ▇▇▇▇▇▇▇’ and Patau’s syndromes Screening (Trisomy 21, 18 &13) as part of the NHS Newborn Blood Spot Fetal Anomaly Screening Programme (NHS NBS) screening servicesFASP). The purpose of the service specification for the NBS Screening Programme is to outline the service and quality indicators expected by NHS England and NHS Improvement for its the population for whom it is responsible population and which meets the evidence base, policies, recommendations and standards of the UK National NHS Screening Committeeprogrammes. The service specification is not designed to replicate, duplicate or supersede any relevant legislative provisions that which may apply, e.g. the Health and Social Care Act 2012 2008 or the work undertaken by the Care Quality Commission. The specification will be reviewed and amended in line with any new guidance as quickly as possible. This specification should be read in conjunction with: • Programme standards current FASP guidance ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/topic/population-screening- programmes/fetal-anomaly • FASP Ultrasound Practitioners Handbook ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/publications/fetal-anomaly- screening-ultrasound-practitioners-handbook • FASP Laboratory Handbook ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/publications/fetal- anomaly-screening-laboratory-handbook-▇▇▇▇▇-▇▇▇▇▇▇▇-and-pataus- syndromes • any separate service specifications for the screening laboratory used by the Provider for antenatal screening services • UK NSC Guidance, Managing Safety Incidents in the English NHS National Screening Programmes ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/publications/managing-safety-incidents-in- nhs-screening-programmes • Guidance & updates on Key Performance Indicators ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/collections/nhs-population- screening-programme-standards • Programme national annual data reporting ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/ collections/newborn-blood-spot-screening-programme-standards-and-data • NHS screening programmes ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/collections/nhs- screening-programmes-national-national- data-reporting • NHS population screening failsafe procedures ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/ collections/nhs-population-screening-failsafe-procedures • Programme supporting publications ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/collections/ newborn-blood-spot-screening-programme-supporting-publications • Safety concerns, safety incidents and serious incidents. Managing Safety Incidents in NHS National Screening Programmes ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/ publications/managing-safety-incidents-in-nhs-screening-programmes • National Institute for Health and Clinical Excellence (NICE) Clinical guideline 37 Routine and postnatal 62 Antenatal care of women and their babies 2006 June 2010 ▇▇▇▇://▇▇▇.▇▇▇▇.▇▇▇.▇▇/ guidance/guidance/cg37 The national screening team in Public CG62 • National Institute for Health England and Clinical Excellence (PHE ScreeningNICE) provides expert advice and support to the NHS Screening ProgrammeClinical guideline CG 129 Antenatal care September 2011 • Royal College of Radiologists. It does those things which make sense to do once rather than by each individual screening service. This includes: • developing and monitoring standards • producing public information leaflets • quality assurance of local screening services • enabling accessible training and education Providers should subscribe to the PHE Screening blog for the latest national news and updates. National documentation and guidance is published on ▇▇▇▇▇://▇▇▇.▇▇.‌‌‌‌▇.▇▇.▇▇/publication/standards- provision-ultrasound-service • Service Specification Number 17 Fetal Anomaly Screening ▇▇▇▇▇://▇▇▇.▇▇▇▇▇▇▇.▇▇▇.▇▇/commissioning/wp-content/uploads/sites/12/2016/04/serv- spec-17-apr16.pdf

Purpose of the Specification. To ensure a consistent and equitable approach across England,, a common national service specification must be used to govern the provision and monitoring of the NHS Newborn Blood Spot Diabetic Eye Screening Programmes (NHS NBS) screening servicesNDESP). The purpose of the service specification for the NBS Screening Programme NDESP is to outline the service and quality indicators expected by NHS England (NHSE) for NHS England’s responsible population. The NDESP was in a development phase during the implementation of the common pathway and NHS Improvement for its responsible population and which that development is now complete. Local providers should now be delivering a service that meets the evidence base, policies, recommendations and standards national service specification. Further developments of the UK National Screening Committeeservice may commence during 2016/17 relating to the implementation of extended screening intervals. The national service specification reflects requirements for any early implementers of that potential development. The service specification is not designed to replicate, duplicate or supersede any relevant legislative provisions that which may apply, e.g. the Health and Social Care Act 2012 2008 or the work undertaken by the Care Quality Commission. The specification will be reviewed and amended in line with any new guidance as quickly as possible. This service specification should needs to be read in conjunction withwith the current NDESP guidance and recommendations. These can be found on the NDESP website: • NHS DESP Programme standards Standards: Guidance and updates on KPIs: ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/publications/young-person-and-adult- screening-submit-key-performance-indicator-data NDESP Operational Guidance: ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/collections/nhsdiabetic-population- screeningeye-programme-standards • Programme national annual data reporting ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/ collections/newborn-blood-spot-screening-programme-standardsscreening- commission-and-data • provide Guidance on Failsafe: NHS screening programmes ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/collections/nhs- screening-programmes-national-data-reporting • NHS population screening failsafe procedures ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/ collections/nhs-population-screening-failsafe-procedures • Programme supporting publications ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/collections/ newborn-blood-spot-screening-programme-supporting-publications • Safety concernsScreening Programmes Guidance, safety incidents and serious incidents. Managing Safety Serious Incidents in the English NHS National Screening Programmes ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/ /government/publications/managing-safety-incidents-in-in- nhs-screening-programmes • National Institute for Health and Clinical Excellence (NICE) Clinical guideline 37 Routine and postnatal care of women and their babies 2006 ▇▇▇▇://▇▇▇.▇▇▇▇.▇▇▇.▇▇/ guidance/cg37 The national screening team in Public Health England (PHE Screening) provides expert advice and support to the NHS Screening Programme. It does those things which make sense to do once rather than by each individual screening service. This includes: • developing and monitoring standards • producing public information leaflets • quality assurance of local screening services • enabling accessible training and education Providers should subscribe to the PHE Screening blog for the latest national news and updates. National documentation and guidance is published on ▇▇▇.▇▇.‌‌‌‌programmes

Purpose of the Specification. To ensure a consistent and equitable approach across England,England a common national service specification must be used to govern the provision and monitoring of fetal anomaly ultrasound screening services as part of the NHS Newborn Blood Spot Fetal Anomaly Screening Programme (NHS NBS) screening servicesFASP). The purpose of the service specification for the NBS Screening Programme is to outline the service and quality indicators expected by NHS England and NHS Improvement for its the population for whom it is responsible population and which meets the evidence base, policies, recommendations and standards of the UK National Screening CommitteeNHS Fetal anomaly screening programme. The service This specification is not designed designated to replicate, duplicate or supersede any relevant anyrelevant legislative provisions that which may apply, e.g. of the Health and Social Care Act 2012 2008 or the work undertaken by the Care Quality Commission. The specification will be reviewed and amended in line with any new guidance as quickly as possible. This specification should be read in conjunction with: • Programme standards current FASP guidance ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/topic/population-screening- programmes/fetal-anomaly • FASP Screening programme handbook ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/publications/fetal-anomaly-screening- programme-handbook . • FASP Ultrasound Practitioners Handbook ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/publications/fetal-anomaly-screening-ultrasound- practitioners-handbook • FASP Laboratory Handbook ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/publications/fetal- anomaly-screening-laboratory-handbook-▇▇▇▇▇-▇▇▇▇▇▇▇-and-pataus- syndromes • any separate service specifications for the screening laboratory used by the Provider for antenatal screening services • UK NSC Guidance, Managing Safety Incidents in the English NHS National Screening Programmes ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/publications/managing-safety-incidents-in- nhs-screening-programmes • Guidance & updates on Key Performance Indicators can be found at ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/collections/nhs-population- screening-programme-standards • Programme national annual data reporting ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/ collections/newborn-blood-spot-screening-programme-standards-and-data • NHS screening programmes ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/collections/nhs- screening-programmes-national-national- data-reporting • NHS population screening failsafe procedures ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/ collections/nhs-population-screening-failsafe-procedures • Programme supporting publications ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/collections/ newborn-blood-spot-screening-programme-supporting-publications • Safety concerns, safety incidents and serious incidents. Managing Safety Incidents in NHS National Screening Programmes ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/ publications/managing-safety-incidents-in-nhs-screening-programmes • National Institute for Health and Clinical Excellence (NICE) Clinical guideline 37 Routine and postnatal 62 Antenatal care of women and their babies 2006 June 2010 ▇▇▇▇://▇▇▇.▇▇▇▇.▇▇▇.▇▇/ guidance/guidance/cg37 The national screening team in Public CG62 • National Institute for Health England and Clinical Excellence (PHE ScreeningNICE) provides expert advice and support to the NHS Screening Programme. It does those things which make sense to do once rather than by each individual screening service. This includes: • developing and monitoring standards • producing public information leaflets • quality assurance of local screening services • enabling accessible training and education Providers should subscribe to the PHE Screening blog for the latest national news and updates. National documentation and guidance is published on Clinical guideline CG 129 Antenatal care September 2011 ▇▇▇▇://▇▇▇.▇▇.‌‌‌‌▇▇.▇▇▇.▇▇/guidance/CG129 • Royal College of Radiologists. Providing an Ultrasound Service ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇.▇▇/publication/standards-provision-ultrasound-service • Service specification No16 NHS Fetal Anomaly Screening Programme – Screening for Down’s, ▇▇▇▇▇▇▇’ and Patau’s syndromes ( trisomy 21,18 & 13) ▇▇▇▇▇://▇▇▇.▇▇▇▇▇▇▇.▇▇▇.▇▇/commissioning/wp- content/uploads/sites/12/2016/04/serv-spec-16-apr16.pdf

Purpose of the Specification. To ensure a consistent and equitable approach across England,, a common national service specification must be used to govern the provision and monitoring of the NHS Newborn Blood Spot Diabetic Eye Screening Programmes (NHS NBS) screening servicesNDESP). The purpose of the service specification for the NBS Screening Programme NDESP is to outline the service and quality indicators expected by NHS England (NHSE) for NHS England’s responsible population. Local providers should be delivering a service that incorporates the common pathway and NHS Improvement for its responsible population and which meets the evidence basenational service specification. NDESP is currently in a development phase relating to the implementation of extended screening intervals and a single national IT solution. For 2017-2018, policies, recommendations and standards the national service specification reflects requirements for any potential early implementers of the UK National Screening Committeethis development. The service specification is not designed to replicate, duplicate or supersede any relevant legislative provisions that which may apply, e.g. the Health and Social Care Act 2012 2008 or the work undertaken by the Care Quality Commission. The specification will be reviewed and amended in line with any new guidance as quickly as possible. This service specification should needs to be read in conjunction withwith the current NDESP guidance and recommendations. These can be found on the NDESP website: • NHS DESP Programme standards Standards: Guidance and updates on KPIs: ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/publications/young-person-and-adult- screening-submit-key-performance-indicator-data NDESP Operational Guidance: ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/collections/nhsdiabetic-population- screeningeye-programme-standards • Programme national annual data reporting ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/ collections/newborn-blood-spot-screening-programme-standardsscreening- commission-and-data • provide Guidance on Failsafe: NHS screening programmes ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/collections/nhs- screening-programmes-national-data-reporting • NHS population screening failsafe procedures ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/ collections/nhs-population-screening-failsafe-procedures • Programme supporting publications ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/collections/ newborn-blood-spot-screening-programme-supporting-publications • Safety concernsScreening Programmes Guidance, safety incidents and serious incidents. Managing Safety Serious Incidents in the English NHS National Screening Programmes ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/ /government/publications/managing-safety-incidents-in-in- nhs-screening-programmes • National Institute for Health and Clinical Excellence (NICE) Clinical guideline 37 Routine and postnatal care of women and their babies 2006 ▇▇▇▇://▇▇▇.▇▇▇▇.▇▇▇.▇▇/ guidance/cg37 The national screening team in Public Health England (PHE Screening) provides expert advice and support to the NHS Screening Programme. It does those things which make sense to do once rather than by each individual screening service. This includes: • developing and monitoring standards • producing public information leaflets • quality assurance of local screening services • enabling accessible training and education Providers should subscribe to the PHE Screening blog for the latest national news and updates. National documentation and guidance is published on ▇▇▇.▇▇.‌‌‌‌programmes

Purpose of the Specification. To ensure a consistent and equitable approach across England,England a common national service specification must be used to govern the provision and monitoring of the NHS Newborn Blood Spot and Infant Physical Examination (NHS NBSNIPE) screening services. The purpose of the service specification for the NBS NHS Newborn and Infant Physical Examination (NIPE) Screening Programme is to outline the service and quality indicators expected by NHS England and (NHS Improvement E) for its the population for whom it is responsible population and which meets the evidence base, policies, recommendations and standards of the UK National NHS Screening Committee. Programmes The service specification is not designed to replicate, duplicate or supersede any relevant legislative provisions that which may apply, e.g. the Health and Social Care Act 2012 2008 or the work undertaken by the Care Quality Commission. The specification will be reviewed and amended in line with any new guidance as quickly as possible. This specification should be read in conjunction with: •  Newborn and Infant Physical Examination Programme Standards ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/publications/newborn-and-infant- physical-examination-screening-standards  Newborn and Infant Physical Examination Programme Handbook ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/publications/newborn-and-infant- physical-examination-programme-handbook  NHS screening programmes: national data reporting ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/collections/nhs-population- screening-programme-standards • Programme national annual data reporting ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/ collections/newborn-blood-spot-screening-programme-standards-and-data • NHS screening programmes ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/collections/nhs- screening-screening- programmes-national-data-reporting • NHS population screening failsafe procedures ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/ collections/nhs-population-screening-failsafe-procedures • Programme supporting publications ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/collections/ newborn-blood-spot-screening-programme-supporting-publications • Safety concerns, safety incidents and serious incidents.  Managing Safety Incidents in NHS National Screening Programmes ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/ /government/publications/managing-safety-safety- incidents-in-nhs-screening-programmes •  National Institute for Health and Clinical Excellence (NICE) Clinical guideline 37 Routine ▇▇▇▇▇▇▇ and postnatal care of women and their babies 2006 ▇▇▇▇://▇▇▇.▇▇▇▇.▇▇▇.▇▇/ guidance/guidance/cg37 The national screening team in Public Health England (PHE Screening) provides expert advice and support to the NHS Screening Programme. It does those things which make sense to do once rather than by each individual screening service. This includes: • developing and monitoring standards • producing public information leaflets • quality assurance of local screening services • enabling accessible training and education Providers should subscribe to the PHE Screening blog for the latest national news and updates. National documentation and guidance is published on ▇▇▇.▇▇.‌‌‌‌cg37

Purpose of the Specification. To ensure a consistent and equitable approach across England,, a common national service specification must be used to govern the provision and monitoring of the NHS Newborn Blood Spot Diabetic Eye Screening Programmes (NHS NBS) screening servicesNDESP). The purpose of the service specification for the NBS Screening Programme NDESP is to outline the service and quality indicators expected by NHS England and NHS Improvement (NHSE) for its responsible population and which meets the evidence base, policies, recommendations and standards of the UK National Screening Committeepopulation. The service specification is not designed to replicate, duplicate or supersede any relevant legislative provisions that which may apply, e.g. the Health and Social Care Act 2012 2008 or the work undertaken by the Care Quality Commission. The specification will be reviewed and amended in line with any new guidance as quickly as possible. This service specification should needs to be read in conjunction withwith the current NDESP guidance and recommendations. These can be found on the NDESP website: • ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/topic/population-screening-programmes/diabetic-eye NHS DESP Programme standards Standards: Guidance and updates on KPIs: ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/publications/young- person-and-adult-screening-submit-key-performance-indicator-data NDESP Operational Guidance: ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/collections/nhsdiabetic-population- eye- screening-programme-standards • Programme national annual data reporting ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/ collections/newborn-blood-spot-screening-programme-standardscommission-and-data • provide Guidance on Failsafe: NHS screening programmes ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/collections/nhs- screening-programmes-national-data-reporting • NHS population screening failsafe procedures ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/ collections/nhs-population-screening-failsafe-procedures • Programme supporting publications ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/collections/ newborn-blood-spot-screening-programme-supporting-publications • Safety concernsScreening Programmes Guidance, safety incidents and serious incidents. Managing Safety Serious Incidents in the English NHS National Screening Programmes ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/ /government/publications/managing-managing- safety-incidents-in-nhs-screening-programmes • National Institute for Health and Clinical Excellence (NICE) Clinical guideline 37 Routine and postnatal care of women and their babies 2006 ▇▇▇▇://▇▇▇.▇▇▇▇.▇▇▇.▇▇/ guidance/cg37 The national screening team in Public Health England (PHE Screening) provides expert advice and support to the NHS Screening Programme. It does those things which make sense to do once rather than by each individual screening service. This includes: • developing and monitoring standards • producing public information leaflets • quality assurance of local screening services • enabling accessible developing and commissioning training and education Providers should subscribe to the PHE Screening blog for the latest national news and updates. National documentation and guidance is published on ▇▇▇.▇▇.‌‌‌‌.

Purpose of the Specification. To ensure a consistent and equitable approach across England,England a common national service specification must be used to govern the provision and monitoring of Down’s, ▇▇▇▇▇▇▇’ and Patau’s syndromes Screening (Trisomy 21, 18 &13) as part of the NHS Newborn Blood Spot Fetal Anomaly Screening Programme (NHS NBS) screening servicesFASP). The purpose of the service specification for the NBS Screening Programme is to outline the service and quality indicators expected by NHS England and NHS Improvement for its the population for whom it is responsible population and which meets the evidence base, policies, recommendations and standards of the UK National NHS Screening Committeeprogrammes. The service specification is not designed to replicate, duplicate or supersede any relevant legislative provisions that which may apply, e.g. the Health and Social Care Act 2012 2008 or the work undertaken by the Care Quality Commission. The specification will be reviewed and amended in line with any new guidance as quickly as possible. This specification should be read in conjunction with: • Programme standards current FASP guidance ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/topic/population-screening- programmes/fetal-anomaly • FASP Ultrasound Practitioners Handbook ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/publications/fetal-anomaly- screening-ultrasound-practitioners-handbook • FASP Laboratory Handbook ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/publications/fetal- anomaly-screening-laboratory-handbook-▇▇▇▇▇-▇▇▇▇▇▇▇-and-pataus- syndromes • any separate service specifications for the screening laboratory used by the Provider for antenatal screening services • UK NSC Guidance, Managing Safety Incidents in the English NHS National Screening Programmes ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/publications/managing-safety-incidents-in- nhs-screening-programmes • Guidance & updates on Key Performance Indicators ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/collections/nhs-population- screening-programme-standards • Programme national annual data reporting ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/ collections/newborn-blood-spot-screening-programme-standards-and-data • NHS screening programmes ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/collections/nhs- screening-programmes-national-national- data-reporting • NHS population screening failsafe procedures ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/ collections/nhs-population-screening-failsafe-procedures • Programme supporting publications ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/collections/ newborn-blood-spot-screening-programme-supporting-publications • Safety concerns, safety incidents and serious incidents. Managing Safety Incidents in NHS National Screening Programmes ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/ publications/managing-safety-incidents-in-nhs-screening-programmes • National Institute for Health and Clinical Excellence (NICE) Clinical guideline 37 Routine and postnatal 62 Antenatal care of women and their babies 2006 June 2010 ▇▇▇▇://▇▇▇.▇▇▇▇.▇▇▇.▇▇/ guidance/guidance/cg37 The national screening team in Public CG62 • National Institute for Health England and Clinical Excellence (PHE ScreeningNICE) provides expert advice and support to the NHS Screening ProgrammeClinical guideline CG 129 Antenatal care September 2011 • Royal College of Radiologists. It does those things which make sense to do once rather than by each individual screening service. This includes: • developing and monitoring standards • producing public information leaflets • quality assurance of local screening services • enabling accessible training and education Providers should subscribe to the PHE Screening blog for the latest national news and updates. National documentation and guidance is published on ▇▇▇▇▇://▇▇▇.▇▇.‌‌‌‌▇.▇▇.▇▇/publication/standards- provision-ultrasound-service • Service Specification Number 17 Fetal Anomaly Screening ▇▇▇▇▇://▇▇▇.▇▇▇▇▇▇▇.▇▇▇.▇▇/commissioning/wp-content/uploads/sites/12/2016/02/serv- spec-17.pdf • ‘Maternity Pathway Payments: Who pays for what?-Aspects of the Maternity Pathway Payment for the Screening and Immunisations Programmes June 2015 ▇▇▇▇▇://▇▇▇.▇▇▇▇▇▇▇.▇▇▇.▇▇/expo/wp- content/uploads/sites/18/2015/06/who-pays-mpp-upd-06-2015.pdf

Purpose of the Specification. To ensure a consistent and equitable approach across England,England a common national service specification must be used to govern the provision and monitoring of the linked antenatal and newborn NHS Newborn Blood Spot Sickle Cell and Thalassaemia (NHS NBSSCT) screening servicesScreening Programme. The purpose of the service specification for the NBS Screening Programme is to outline the service and quality indicators expected by NHS England and (NHS Improvement E) for its NHS E responsible population and which meets the evidence base, policies, recommendations and standards of the UK National NHS Screening CommitteeProgrammes. The service specification is not designed to replicate, duplicate or supersede any relevant legislative provisions that which may apply, e.g. the Health and Social Care Act 2012 2008 or the work undertaken by the Care Quality Commission. The specification will be reviewed and amended in line with any new guidance as quickly as possible. This specification should needs to be read in conjunction withwith the following: • SCT Screening Programme standards Standards ▇▇▇▇://▇▇▇.▇▇▇▇▇▇▇▇▇.▇▇▇.▇▇/standards ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/collections/nhs-population- population-screening-programme-programme- standards • Programme national annual data reporting Sickle Cell and Thalassaemia Handbook for Laboratories ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/ collections/government/newbornpublications/sickle-blood-spot-screening-programme-standardscell-and-data • thalassaemia-screening- handbook-for-laboratories NHS screening programmes Newborn Blood Spot Screening Programme service specification. ▇▇▇▇▇://▇▇▇.▇▇▇▇▇▇▇.▇▇▇.▇▇/commissioning/wp-content/uploads/sites/12/2016/04/serv- spec-19-chld-blood-spot-screening.pdf Specialised Haemoglobinopathy Services definition as set out in the Manual for prescribed specialised services The Specification for Specialised Services for Haemoglobinopathy Care (All Ages) (B08/S/a) NICE clinical guideline 62. Antenatal care ▇▇▇▇▇://▇▇▇.▇▇▇▇.▇▇▇.▇▇/guidance/cg62 NICE Clinical Guideline 110. Pregnancy and Social Complex Factors: A Model for Service Provision for Pregnant Women with Complex Social Factors. ▇▇▇▇▇://▇▇▇.▇▇▇▇.▇▇▇.▇▇/guidance/cg110 Guidance and updates on KPIs ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/collections/nhs- screening-programmes-national-data-reporting • NHS population screening failsafe procedures ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/ collections/nhs-population-screening-failsafe-procedures • Programme supporting publications ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/collections/ newborn-blood-spot-screening-programme-supporting-publications • Safety concernsScreening Programmes guidance, safety incidents and serious incidents. Managing Safety Serious Incidents in the English NHS National Screening Programmes ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/ /government/publications/managing-safety-incidents-in-nhs-nhs- screening-programmes • National Institute Who pays for Health and Clinical Excellence (NICE) Clinical guideline 37 Routine and postnatal care what: Aspects of women and their babies 2006 ▇▇▇▇://▇▇▇.▇▇▇▇.▇▇▇.▇▇/ guidance/cg37 The national screening team in Public Health England (PHE Screening) provides expert advice and support to the NHS Screening Programme. It does those things which make sense to do once rather than by each individual screening service. This includes: • developing and monitoring standards • producing public information leaflets • quality assurance of local screening services • enabling accessible training and education Providers should subscribe to the PHE Screening blog maternity pathway payment for the latest national news screening and updates. National documentation and guidance is published on ▇▇▇.▇▇.‌‌‌‌immunisation programmes June 2015